• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 17 Feb 2025

Investment Companies Research - Investment Companies - An emphatic 7-0 victory, but little cause for celebration


3i Infrastructure PLC (3IN:LON), 350 | Aberforth Smaller Companies Trust PLC (ASL:LON), 0 | Aberdeen Asian Income Fund Limited (AAIF:LON), 252 | abrdn Diversified Income and Growth PLC GBP (ADIG:LON), 46.2 | abrdn European Logistics Income PLC (ASLI:LON), 33.6 | abrdn Property Income Trust Limited (API:LON), 5.5 | Allianz Technology Trust PLC (ATT:LON), 494 | Ashoka India Equity Investment Trust Plc (AIE:LON), 274 | AVI Global Trust PLC GBP (AGT:LON), 265 | Baillie Gifford China Growth Trust Plc (BGCG:LON), 0 | Baillie Gifford European Growth Trust PLC GBP (BGEU:LON), 0 | Baillie Gifford Japan Trust PLC (BGFD:LON), 0 | Baillie Gifford US Growth Trust Plc (USA:LON), 270 | Bellevue Healthcare Trust Plc (BBH:LON), 118 | BH Macro Ltd GBP (BHMG:LON), 0 | BioPharma Credit PLC USD (BPCR:LON), 91.3 | Biotech Growth Trust PLC (BIOG:LON), 952 | BlackRock Frontiers Investment Trust PLC (BRFI:LON), 172 | Blackrock Smaller Companies Trust PLC (BRSC:LON), 0 | BlackRock Throgmorton Trust PLC GBP (THRG:LON), 586 | Blackrock World Mining Trust PLC (BRWM:LON), 618 | Bluefield Solar Income Fund Ltd. (BSIF:LON), 84.2 | Caledonia Investments PLC (CLDN:LON), 376 | Capital Gearing Trust PLC GBP (CGT:LON), 0 | City of London Investment Trust PLC (CTY:LON), 498 | Cordiant Digital Infrastructure Limited (CORD:LON), 97.5 | Digital 9 Infrastructure Plc (DGI9:LON), 8.9 | Diverse Income Trust PLC GBP (DIVI:LON), 102 | Edinburgh Investment Trust PLC (EDIN:LON), 792 | Edinburgh Worldwide Investment Trust (EWI:LON), 0 | Empiric Student Property Plc (ESP:LON), 90.7 | European Opportunities Trust PLC GBP (EOT:LON), 929 | F&C Investment Trust PLC GBP (FCIT:LON), 1,184 | Fair Oaks Income Limited 2021 Shs USD (FAIR:LON), 52.5 | Fidelity Asian Values PLC GBP (FAS:LON), 584 | Fidelity China Special Situations PLC (FCSS:LON), 324 | Fidelity European Trust PLC GBP (FEV:LON), 410 | Fidelity Special Values PLC GBP (FSV:LON), 384 | Finsbury Growth & Income Trust PLC (FGT:LON), 862 | Foresight Solar Fund Limited GBP (FSFL:LON), 76.2 | GCP Asset Backed Income Fund Ltd. (GABI:LON), 66.7

  • Investec Bank
    • Alan Brierley | Ben Newell

    • 4 pages


 

This content is only available within our institutional offering.

Sign in

This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account

This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account


Sign In
Not a commercial user? Register here for our wider research bundle

Investment Companies Research - Investment Companies - An emphatic 7-0 victory, but little cause for celebration


3i Infrastructure PLC (3IN:LON), 350 | Aberforth Smaller Companies Trust PLC (ASL:LON), 0 | Aberdeen Asian Income Fund Limited (AAIF:LON), 252 | abrdn Diversified Income and Growth PLC GBP (ADIG:LON), 46.2 | abrdn European Logistics Income PLC (ASLI:LON), 33.6 | abrdn Property Income Trust Limited (API:LON), 5.5 | Allianz Technology Trust PLC (ATT:LON), 494 | Ashoka India Equity Investment Trust Plc (AIE:LON), 274 | AVI Global Trust PLC GBP (AGT:LON), 265 | Baillie Gifford China Growth Trust Plc (BGCG:LON), 0 | Baillie Gifford European Growth Trust PLC GBP (BGEU:LON), 0 | Baillie Gifford Japan Trust PLC (BGFD:LON), 0 | Baillie Gifford US Growth Trust Plc (USA:LON), 270 | Bellevue Healthcare Trust Plc (BBH:LON), 118 | BH Macro Ltd GBP (BHMG:LON), 0 | BioPharma Credit PLC USD (BPCR:LON), 91.3 | Biotech Growth Trust PLC (BIOG:LON), 952 | BlackRock Frontiers Investment Trust PLC (BRFI:LON), 172 | Blackrock Smaller Companies Trust PLC (BRSC:LON), 0 | BlackRock Throgmorton Trust PLC GBP (THRG:LON), 586 | Blackrock World Mining Trust PLC (BRWM:LON), 618 | Bluefield Solar Income Fund Ltd. (BSIF:LON), 84.2 | Caledonia Investments PLC (CLDN:LON), 376 | Capital Gearing Trust PLC GBP (CGT:LON), 0 | City of London Investment Trust PLC (CTY:LON), 498 | Cordiant Digital Infrastructure Limited (CORD:LON), 97.5 | Digital 9 Infrastructure Plc (DGI9:LON), 8.9 | Diverse Income Trust PLC GBP (DIVI:LON), 102 | Edinburgh Investment Trust PLC (EDIN:LON), 792 | Edinburgh Worldwide Investment Trust (EWI:LON), 0 | Empiric Student Property Plc (ESP:LON), 90.7 | European Opportunities Trust PLC GBP (EOT:LON), 929 | F&C Investment Trust PLC GBP (FCIT:LON), 1,184 | Fair Oaks Income Limited 2021 Shs USD (FAIR:LON), 52.5 | Fidelity Asian Values PLC GBP (FAS:LON), 584 | Fidelity China Special Situations PLC (FCSS:LON), 324 | Fidelity European Trust PLC GBP (FEV:LON), 410 | Fidelity Special Values PLC GBP (FSV:LON), 384 | Finsbury Growth & Income Trust PLC (FGT:LON), 862 | Foresight Solar Fund Limited GBP (FSFL:LON), 76.2 | GCP Asset Backed Income Fund Ltd. (GABI:LON), 66.7

  • Published: 17 Feb 2025
  • Author: Alan Brierley | Ben Newell
  • Pages: 4
  • Investec Bank


Investec view: In our report, Time to man the barricades against an egregious and opportunistic attack, but also for some industry self-reflection, we expressed deep concerns about Saba’s proposals, which in our view, went beyond the “greenmail” that Warren Buffett had previously described as “odious and repugnant”. We highlighted how Saba had failed to provide even basic information on key fundamental issues while, given bewildering corporate governance proposals, we questioned the level of shareholder protection should Saba be successful. Last Friday, shareholders of Edinburgh Worldwide voted decisively against all the requisitioned resolutions. In the initial salvo, not only has Saba lost 7-0, but the magnitude of the defeat in each case, sends a strong message. Despite claims of significant support, the total value of shares, from the “miserable seven” companies, that supported Saba was a rather miserable c.£16m vs. an aggregate market capitalisation of £3.7bn. While Saba has appeared intoxicated on US exceptionalism, the first wave of the campaign has been a spectacular failure, which appears only to have succeeded in galvanising an entire industry against it. Given this backdrop, a rethink was urgently required by Saba, and we didn’t have to wait long to find out what it would be. Earlier last week, Saba launched the second wave, which is greenmail, pure and simple. However, in shifting the focus now to open-ending these trusts, Saba again appears to be missing the point. Spurious rhetoric around “trapped” investors and “long overdue liquidity at NAV” strikes a hollow tone given what we see as Saba’s very clear motives, and conveniently ignores the fact that shareholders have deliberately chosen to buy into these closed-ended vehicles, rather than open-ended equivalents, for good reasons. We strongly believe that investment companies have inherent structural competitive advantages that should underpin superior long-term returns. Critically, this includes the ability to take a long-term approach to portfolio management, without having to worry about cash-flows from new investment/redemptions, which are often at the wrong time in the cycle; and this impact is even more pronounced for smaller, more illiquid investments. In addition, investment companies can employ gearing to enhance returns. It was interesting listening to the Annual Investor Meeting of Pershing Square Holdings (PSH.L, Buy) last week, where Bill Ackman spoke about the “enormous competitive advantage of permanent capital”. Maybe, the venerable Mr Ackman is onto something here. While Saba’s initial ham-fisted attack on the UK closed end industry has been decisively repelled, there is little cause for celebration. Saba has quickly modified its strategy, and the industry must accept Saba is unlikely to be going anywhere, anytime soon. Moreover, while discounts remain stressed, there is a clear risk that this may attract further short-term investors. Accordingly, while we have been encouraged by greater proactivity in the past 18 months, including corporate actions, mergers, increased buybacks, tender offers and changes to fee arrangements, it is critical that the industry accelerates efforts to narrow discounts and dampen discount volatility. There can be no room for any further complacency, and the industry must do whatever it takes to ensure a perfect storm doesn’t become an existential crisis.

More Content

More Content

The Biotech Growth Trust in 60 seconds

Companies: Biotech Growth Trust PLC

Edison

Capital Network's Riccardo Lowi on BB Healthcare Trust PLC

Companies: Bellevue Healthcare Trust Plc

Proactive

Foresight Solar Fund's Ross Driver on H1 2025 results, buyback and growth pipeline

Companies: Foresight Solar Fund Limited GBP

Proactive

BB Healthcare Trust expect healthcare rally in immediate after-effect of US election to continue

Companies: Bellevue Healthcare Trust Plc

Proactive

Baillie Gifford US Growth

Companies: Baillie Gifford US Growth Trust Plc

Kepler | Trust Intelligence
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
  • LLM Feed
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Bowsprit Partners Limited
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In